1. Home
  2. HIPO vs AURA Comparison

HIPO vs AURA Comparison

Compare HIPO & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

HOLD

Current Price

$27.76

Market Cap

748.8M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.05

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIPO
AURA
Founded
2015
2007
Country
United States
United States
Employees
540
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
748.8M
713.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HIPO
AURA
Price
$27.76
$7.05
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$38.67
$20.00
AVG Volume (30 Days)
160.9K
602.2K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.28
N/A
Revenue Next Year
$22.33
N/A
P/E Ratio
$7.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.08
$4.73
52 Week High
$38.98
$9.54

Technical Indicators

Market Signals
Indicator
HIPO
AURA
Relative Strength Index (RSI) 49.68 52.02
Support Level $27.00 $6.58
Resistance Level $29.43 $7.83
Average True Range (ATR) 0.97 0.35
MACD -0.21 0.02
Stochastic Oscillator 30.71 64.63

Price Performance

Historical Comparison
HIPO
AURA

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: